drugset / Trial / NCT03232632
Assessment of Cardiac Fixation During PET Using a New Drug Within Amyloid Cardiac Injuries.
NaSingle-groupOpen-labelSupportive care
Summary
To estimate distribution's parameters of 18F-Flutemetamol (Vizamyl®) fixation on myocardium for patients with amyloid cardiac injuries.
Timeline
- Start
- 2017-03-15
- Primary completion
- 2019-09-15
- Completion
- 2019-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-Flutemetamol | Diagnostic / imaging agent | — | — |